Determination of serum insulin-like growth factor-I reference values for the automated chemiluminescent Liaison assay. Clinical utility in the follow-up of patients with treated acromegaly.
Massart C, Poirier JY
Purpose
Conclusion
Studies (2)
Purpose
The purpose of this study was to determine the effects of age, gender, and assay on serum IGF-I levels in healthy donors and patients with acromegaly.
Summary of Findings
The reference range of serum IGF-I concentrations in healthy individuals decreased with age. Median values were lower in men than in women, with the exception of the 61-75 year age range. Notably, only half as many subjects were included in this age range. While lower levels of IGF-I were measured by the Liaison assay compared with the Immunotech assay, results for patients with acromegaly were well correlated between the two assay types (r=0.899). Further, 62.1% and 65.7% of serum specimens from patients with acromegaly had levels of IGF-I within normal ranges as determined by the Liaison and Immunotech assays, respectively. The authors note that the reference values given by the Liaison manufacturer appear to be slightly inaccurate.
Biospecimens
FluidSerumFluidBloodPreservation Types
FrozenDiagnoses
NormalOther diagnosesPlatforms
ProteinRadioimmunoassayProteinChemiluminescencePre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition AcromegalyPreaquisition Patient age 29-40 y41-50 y51-60 y61-75 yPreaquisition Patient gender FemaleMaleRadioimmunoassay Specific Technology platform Chemiluminescence
Purpose
Summary of Findings
Biospecimens
FluidSerumPreservation Types
FrozenDiagnoses
NormalPlatforms
ProteinRadioimmunoassayPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Biomarker level 105 to 1100 ug/L IGF-IStorage Storage duration 5 yStorage Storage temperature -80 degrees C